Articles > Popular publications > PR Newswire press releases > July-September 2009 > Wednesday, July 22

Article: University of Lodz Invests in the Unique Cellaxess(R)HT System for Research on Multidrug Resistance Genes in Cancer.

Article from:
PR Newswire
Article date:
July 22, 2009
Copyright

GOTHENBURG, Sweden, July 22 /PRNewswire/ -- Cellectricon, a leading provider of cell-based screening solutions for research and drug discovery, today announced its collaboration with University of Lodz, Poland. Under the agreement University of Lodz invests in Cellaxess(R)HT, the world's first system for high throughput transfection enabling reagent-free delivery of any genetic material to cells. 

 
  To view the Multimedia News Release, please click: 
  http://www.prnewswire.com/mnr/cellectricon/39261/

"We are excited about the collaboration with Cellectricon and believe the Cellaxess(R)HT system will greatly advance our efforts in our research program ... 







Read all of this article with a FREE trial
















Related newspaper, magazine, and journal articles:









  




 

    

 
 
   
 


   
  
  Article: Cellectricon Receives Milestone Order for Cellaxess(R)HT, ...

  
  PR Newswire Europe; 
  November 12, 2008 ;  
  
  
 
  700+ words
... ... Cellectricon has developed the Cellaxess(R)HT system in close collaboration with ... biologically relevant cell types." Cellaxess(R)HT is the world's ... pharmaceutical development, the Cellaxess(R)HT System enables high throughput RNAi ... 







   
 




  




 

    

 
 
   
 


   
  
  Article: Cellectricon Receives Milestone Order for Cellaxess(R)HT, ...

  
  PR Newswire; 
  November 12, 2008 ;  
  
  
 
  700+ words
... ... Cellectricon has developed the Cellaxess(R)HT system in close collaboration with ... biologically relevant cell types." Cellaxess(R)HT is the world's ... pharmaceutical development, the Cellaxess(R)HT System enables high throughput RNAi ... 







   
 




  




 

    

 
 
   
 


   
  
  Article: Harvard Medical School and Cellectricon Collaborates Around ...

  
  PR Newswire Europe; 
  November 25, 2008 ;  
  
  
 
  700+ words
... ... ICCB-L) will utilize the Cellaxess(R)HT system, the world's first system ... opportunity we have to evaluate Cellaxess(R)HT for genome-wide ... pharmaceutical development, the Cellaxess(R)HT System enables high throughput RNAi ... 







   
 




  




 

    

 
 
   
 


   
  
  Article: Biocontrol Subsidiary, IDT, Receives FDA Marketing Clearance For ...

  
  PR Newswire; 
  January 12, 2000 ;  
  
  
 
  700+ words
... ... clearance to market the ThermoChem-HT System(TM) and related disposables. The ThermoChem-HT System and disposables will now be available ... The intended use of the ThermoChem-HT System is to raise the core temperature of the ... 







   
 




  




 

    

 
 
   
 


   
  
  Article: ThermoChem(TM) HT System Unveiled at Leading Cancer ...

  
  PR Newswire; 
  March 27, 2001 ;  
  
  
 
  700+ words
... ... circulated by products like the ThermoChem HT System, that causes the abdominal region to ... of 109.4 degrees F. The ThermoChem HT System offers a substantial advance in the delivery ... management into a single unit. The ThermoChem HT System is the only FDA cleared device for this ... 







   
 




  




 

    

 
 
   
 


   
  
  Article: BICO Subsidiary, ViaCirQ, Inc., Receives Contract for ...

  
  PR Newswire; 
  August 29, 2000 ;  
  
  
 
  700+ words
... ... Baptist Medical Center with the ThermoChem-HT System(TM) and disposable ThermoChem-HT System packs for all intraperitoneal hyperthermia ... FDA clearance to market the ThermoChem-HT System to raise the core temperature of the abdominal ... 







   
 




  




 

    

 
 
   
 


   
  
  Article: BICO Subsidiary, ViaCirq, and Veterans Medical Center Enter Into ...

  
  PR Newswire; 
  May 23, 2001 ;  
  
  
 
  700+ words
... ... use and evaluate the ThermoChem(TM) HT System as part of an operative procedure to ... IPH treatment, using the ThermoChem HT System, was administered on May 14, 2001 ... procedure, utilizing the ThermoChem HT System, can be marketed to other VA Medical ... 







   
 




  




 

    

 
 
   
 


   
  
  Article: Baylor University Medical Center Adopts ViaCirq's ...

  
  Medical Devices & Surgical Technology Week; 
  January 27, 2002 ;  
  
  
 
  700+ words
... ... Medical Center in Dallas, Texas, to utilize the ThermoChem HT System and related treatment accessory kits for all intraperitoneal ... procedures per year over the three-year agreement. The ThermoChem HT System administers intraperitoneal hyperthermia, which is used as ... 







   
 

























 



 





 






Newsweek
Harper's Magazine
The Washington Post
Chicago Tribune
Crain's Chicago Business
PRNewswire
Pediatric News
The Nation
Advertising Age
The Economist (US)
A FREE trial gives you access to over 80 million articles!
Access over 6,500 publications with a FREE trial!


  



Find articles, research, and archives